South Korea
GNT Pharma Announces Promising Nelonemdaz Results, Initiates Global Phase 3 Stroke Trials
** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Mult...
December 12, 2024 | News
SNUBH, CurePSP, and GemVax Unite to Establish Korea’s First International PSP Research and Treatment Center
MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center Tackling Global Challenges in an Aging Er...
December 10, 2024 | News
Samsung Biologics Hosts Second Supplier ESG Day, Rallying Global Partners for Sustainable Value Chains
Samsung Biologics , a global contract development and manufacturing organization (CDMO), hosted its second Supplier ESG Day to share insights on sustainabl...
December 03, 2024 | News
Lunit Partners with Mexico's Salud Digna to Advance AI-Driven Cancer Diagnostics Across Latin America
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic partnership with&nbs...
November 28, 2024 | News
South Korea’s Newbase Launches ‘Medicrew,’ Transforming VR-Based Medical Education Globally
Newbase, a leader in metaverse-based medical education platforms, announced on the 28th the launch of its new product, 'Medicrew', a platform designed to p...
November 28, 2024 | News
South Korea’s S.BIOMEDICS Announces Promising Phase 1/2a Data for TED-A9 Cell Therapy in Parkinson’s Disease
-S.BIOMEDICS revealed promising one-year post-transplant data from their Phase 1/2a clinical trial of the TED-A9 cell therapy for Parkinson's disease....
November 27, 2024 | News
HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Complete Phase 1 Study of HL192 (ATH-399A) for Parkinson’s Disease
HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported...
November 26, 2024 | News
GC Biopharma and Novel Pharma Dose First US Patient in Pioneering Clinical Trial for Sanfilippo Syndrome Type A
GC Biopharma and Novel Pharma announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new d...
November 26, 2024 | News
Hanmi Showcases Promising Progress in BH3120 Immunotherapy at SITC 2024
Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S.Phase 1 trial is progressing smoothly, with n...
November 25, 2024 | News
Mongolian Health Officials Tour SD Biosensor Facilities in Korea to Strengthen Infectious Disease Collaboration
A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factori...
November 21, 2024 | News
Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value
The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...
November 20, 2024 | News
Lunit and AstraZeneca Collaborate in South Korea to Transform Lung Cancer Diagnostics with AI-Powered Genotype Predictor
Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations Lunit (KRX:3281...
November 19, 2024 | News
Everest Medicines' NEFECON® Gains Full Approval in South Korea for IgA Nephropathy Treatment
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
November 19, 2024 | News
SK Biopharmaceuticals Partners with KIRAMS to Advance Radiopharmaceutical Cancer Therapies Using Actinium-225
SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates...
November 19, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
